| Tag | Content |
|---|
EnhancerAtlas ID | HS141-11823 |
Organism | Homo sapiens |
Tissue/cell | NB4 |
Coordinate | chr20:47242820-47243740 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Gmeb1 | MA0615.1 | chr20:47243266-47243283 | GTGGTTACGTAAGACGT | + | 6.36 | | TCF3 | MA0522.2 | chr20:47243245-47243255 | AGCAGGTGTT | - | 6.02 | | Zfx | MA0146.2 | chr20:47243595-47243609 | CAGGCCTGGGCCCA | - | 6.06 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_05768 | chr20:47242787-47244324 | Brain_Hippocampus_Middle |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr20 | 47243018 | 47243571 | | chr20 | 47243589 | 47243656 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH20I048626 | chr20 | 47242814 | 47243790 |
|
Enhancer Sequence | CTATATGCAG AGATGGTTTT GGAGCCGGGG GACCAGACAG GAGGCTGCGT GGTGTCCAGG 60
GCAAGCAGAC TGCAATGCTG CACATGTGGT CTGATGTGGT CAGCGCTCGG ACTCCACGCC 120
CAGACTGCCT GGGTTCAGAA TCCCAGCTTT TCCATTTACT AGCTGTGTGA CATTGGACAA 180
GATACTTAAC CTCTCTGTGC CTTAGCGTCC CCACCTGCCA AGTGGGGATG ACAGCCGGAC 240
TTGGCTCACA GGGCAGCTGT TTGGATTAAT GAGTCCACAG AGGGGAAGCA ATTGGACAGT 300
GCGTGGCACA GGGCAAAGGC CGTGAAGGTA TTGAAAGGAA CCACGTGCCA CTCGTGAGAC 360
ACAAACAAGG TGTGTGTGGA GCCCCCAGCG CCACAGCACG CACAGTGACT CTCGTCACCA 420
CTGGCAGCAG GTGTTGCCGG CGCTCTGTGG TTACGTAAGA CGTTGCCGCT GGCGGGGAGC 480
TGCCTGAAGG GTCCATGGAA CTGTGGACTA TTTTTACAAC TTCTTGGGAG TCACATTATT 540
TCAAAACAAG AGTTATTTAA AACTTGTGGG CAGATGACGA CAGCAAACTA GGGCTGTGGA 600
GATGGAGAGA GGATCAGACG GAAACAACGT CATGATCCTA AAGGGCCTAC ATGTGGCACC 660
AAGAGGAAGA CTGAAAACCA CATGAAGAGA GGGCAGGGTG GGAGGACAGG AGGAAACAGC 720
ACTCCCCATG CCAAAGACGG CAGGAACAGA GAGCATTCCT GCAAATCAGG CATCGCAGGC 780
CTGGGCCCAG GCTGCTGTTC AGTTCGCATT TCTGTAAATG GCTAAAAGGT TAGCTTAGGT 840
TGGATCAGCT AAAATCACAG AATTCTTAAT TCCACCCCAG GTTAAAGCGA GCCGCTCAGG 900
GGTCAGGGAC TCAGGGTAGG 920
|
